CN105211884A - For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof - Google Patents
For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof Download PDFInfo
- Publication number
- CN105211884A CN105211884A CN201510528459.3A CN201510528459A CN105211884A CN 105211884 A CN105211884 A CN 105211884A CN 201510528459 A CN201510528459 A CN 201510528459A CN 105211884 A CN105211884 A CN 105211884A
- Authority
- CN
- China
- Prior art keywords
- alimentation composition
- vitamin
- powder
- vegetable oil
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 208000007342 Diabetic Nephropathies Diseases 0.000 title abstract description 28
- 208000033679 diabetic kidney disease Diseases 0.000 title abstract description 28
- 238000000502 dialysis Methods 0.000 title abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 53
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 34
- 239000008157 edible vegetable oil Substances 0.000 claims abstract description 30
- 239000003094 microcapsule Substances 0.000 claims abstract description 29
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 27
- 229940088594 vitamin Drugs 0.000 claims abstract description 25
- 229930003231 vitamin Natural products 0.000 claims abstract description 25
- 235000013343 vitamin Nutrition 0.000 claims abstract description 25
- 239000011782 vitamin Substances 0.000 claims abstract description 25
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 25
- 102000040350 B family Human genes 0.000 claims abstract description 24
- 108091072128 B family Proteins 0.000 claims abstract description 24
- 239000011812 mixed powder Substances 0.000 claims abstract description 18
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 16
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 16
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 18
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 18
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 10
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 10
- 235000020778 linoleic acid Nutrition 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 9
- 229930003451 Vitamin B1 Natural products 0.000 claims description 9
- 229930003779 Vitamin B12 Natural products 0.000 claims description 9
- 229930003471 Vitamin B2 Natural products 0.000 claims description 9
- 108010046377 Whey Proteins Proteins 0.000 claims description 9
- 102000007544 Whey Proteins Human genes 0.000 claims description 9
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 9
- 235000019152 folic acid Nutrition 0.000 claims description 9
- 239000011724 folic acid Substances 0.000 claims description 9
- 229960000304 folic acid Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 235000019161 pantothenic acid Nutrition 0.000 claims description 9
- 239000011713 pantothenic acid Substances 0.000 claims description 9
- 229940055726 pantothenic acid Drugs 0.000 claims description 9
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 229960003495 thiamine Drugs 0.000 claims description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 9
- 235000010374 vitamin B1 Nutrition 0.000 claims description 9
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- 235000019163 vitamin B12 Nutrition 0.000 claims description 9
- 239000011715 vitamin B12 Substances 0.000 claims description 9
- 235000019164 vitamin B2 Nutrition 0.000 claims description 9
- 239000011716 vitamin B2 Substances 0.000 claims description 9
- 239000011726 vitamin B6 Substances 0.000 claims description 9
- 235000019158 vitamin B6 Nutrition 0.000 claims description 9
- 229940011671 vitamin b6 Drugs 0.000 claims description 9
- 235000019486 Sunflower oil Nutrition 0.000 claims description 7
- 235000021388 linseed oil Nutrition 0.000 claims description 7
- 239000000944 linseed oil Substances 0.000 claims description 7
- 239000002600 sunflower oil Substances 0.000 claims description 7
- 239000005862 Whey Substances 0.000 claims description 6
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 150000002617 leukotrienes Chemical class 0.000 claims description 5
- 235000020183 skimmed milk Nutrition 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 239000003813 safflower oil Substances 0.000 claims description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 3
- 102000002322 Egg Proteins Human genes 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 229920001202 Inulin Polymers 0.000 claims description 3
- 108010038807 Oligopeptides Proteins 0.000 claims description 3
- 102000015636 Oligopeptides Human genes 0.000 claims description 3
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 3
- 210000000969 egg white Anatomy 0.000 claims description 3
- 235000014103 egg white Nutrition 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims description 3
- 235000019710 soybean protein Nutrition 0.000 claims description 3
- 235000021119 whey protein Nutrition 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 235000000346 sugar Nutrition 0.000 abstract description 14
- 102000004169 proteins and genes Human genes 0.000 abstract description 11
- 108090000623 proteins and genes Proteins 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 8
- 230000035764 nutrition Effects 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000002641 glycemic effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 108010071690 Prealbumin Proteins 0.000 description 3
- 102000007584 Prealbumin Human genes 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000020832 chronic kidney disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 102000002070 Transferrins Human genes 0.000 description 2
- 108010015865 Transferrins Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000021196 dietary intervention Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000028208 end stage renal disease Diseases 0.000 description 2
- 201000000523 end stage renal failure Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical group C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 101800000128 Small peptide 1 Proteins 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 231100000637 nephrotoxin Toxicity 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a kind of for alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof, belong to field of health care food.Alimentation composition of the present invention comprises the component of following weight parts: albumen powder 1-50 part, small peptide 1-20 part, edible vegetable oil microcapsule powder 10-70 part, dietary fiber 1-30 part, maltodextrin 1-30 part, B family vitamin 0.1-1 part; Its preparation method comprises the following steps: B family vitamin, small peptide and dietary fiber are mixed, and obtains mixed powder A; Albumen powder and maltodextrin are mixed, obtains mixed powder B; By the mixer mixing 20 ~ 40 minutes of mixed powder A, mixed powder B and edible vegetable oil microcapsule powder, obtained alimentation composition.Alimentation composition of the present invention, for providing enough energy and high-quality protein after Diabetic Nephropathy patients dialysis, can improve the nutrition condition after Diabetic Nephropathy patients dialysis, be conducive to the Blood sugar management of Diabetic Nephropathy patients, and its preparation method be simple.
Description
Technical field
The present invention relates to a kind of alimentation composition and preparation method thereof, be specifically related to a kind of for alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof.
Background technology
Along with the change of people life style and the quickening of China's aging paces, CKD has become the important diseases of another threat human health after cardiovascular and cerebrovascular diseases, tumour, diabetes.And diabetic nephropathy is the Important cause of disease of End-stage renal disease in world wide in recent years.Diabetes can aggravate the sclerosis of glomerulus, are to cause one of Diabetic Nephropathy patients main causes of death.
End stage renal disease need carry out continuation dialysis treatment, wherein based on haemodialysis, this kind of method can control the development of ephrosis and extend the life of patient, but carries out dialysis treatment for a long time and easily make the nutrition condition of patient decline, brings out and malnutrition occurs.A large amount of clinical research proves: implement necessary nutritional supplementation after dialysing for nephrotic, especially selects and supplementary high-quality protein is the key of patient being carried out to nutritional support.Further, dialysis crowd must give sufficient heat while giving high-quality protein.If because taking in shortage of heat, cannot ensure that high-quality protein is fully absorbed by human body, the protein in bodily tissue and food by as origin of heat decomposition and consumption, will produce the more metabolic waste increase nephrotoxin.This not only increases the weight of protein malnutrition, more increases the weight of acid poisoning and promotes potassemia.
But due to the particularity that diabetic nephropathy disease is planted, nutritional supplementation need consider in conjunction with diabetes and ephrosis, otherwise the deterioration of diabetes can increase the weight of the state of an illness of ephrosis.Blood sugar causes kidney tissue damage by Hemodynamic Effects, widely glycosylation, polyol pathway, oxidative stress and growth factor approach etc.Glycemic control, in desirable level, can slow down the infringement speed to kidney.Appropriate application glycemic index (GI) scientific guidance diets of diabetic patients, is of great benefit to for regulation and control glycemic index blood sugar for human body.In general, as long as the food of half generates index from hyperglycaemia replace to hypoglycemia patient, just can obtain the effect significantly improving blood sugar, be conducive to Blood sugar management, reduce because blood sugar rises violently the diabetes worsens brought.And common carbohydrate often causes blood sugar to raise after taking in.
In the patent literature, there are some for the formula food of nephrotic, such as, CN101496577B discloses and a kind ofly eats food formula of special diet containing small peptide for nephrotic, CN103478545A discloses a kind of whole-grain total-nutrition formulation food eaten for nephrotic, and CN104115890A discloses the special bread of a kind of diabetic nephropathy and preparation method etc.But according to patent document and non-patent literature, also do not find the nutraceutical that the metabolic characteristic after according to Diabetic Nephropathy patients dialysis and nutritional need are equipped with specially, specific aim is not strong.
Summary of the invention
The object of the invention is to overcome above-mentioned the deficiencies in the prior art part and provide a kind of for alimentation composition edible after Diabetic Nephropathy patients dialysis, this alimentation composition can improve the nutrition condition after Diabetic Nephropathy patients dialysis.
Meanwhile, present invention also offers the above-mentioned preparation method for alimentation composition edible after Diabetic Nephropathy patients dialysis.
For achieving the above object, the technical scheme that the present invention takes is: a kind of alimentation composition, comprises the component of following weight parts: albumen powder 1-50 part, small peptide 1-20 part, edible vegetable oil microcapsule powder 10-70 part, dietary fiber 1-30 part, maltodextrin 1-30 part, B family vitamin 0.1-1 part.
It is primary raw material that above-mentioned edible vegetable oil microcapsule powder refers to edible vegetable oil, with oligomeric maltose, maltodextrin etc. for auxiliary material, adds food additives, through Over emulsfication, shearing, homogeneous, spraying dry and obtained product.
The present invention take high-quality protein as the component of alimentation composition, is conducive to maintaining the nitrogen balance of nephrotic and normal nutritional status, improves body functional condition, alleviates kidney burden; Meanwhile, small peptide is also a kind of desirable high-quality nitrogenous source, and bioavailability is high, has a series of physiological active functions.In addition, common carbohydrate often causes blood sugar to raise after taking in, and the content that the present invention increases dietary fiber in food is then not only conducive to reducing glycemic index (GI), is also improved the effects such as gut flora.
Alimentation composition of the present invention is with high-quality protein and aliphatic acid for key component, and scientific matching small peptide, dietary fiber and vitamin, effectively can supplement for dialysis crowd especially Diabetic Nephropathy patients carries out protein energy, improve the nutrition condition after dialysis.
As the preferred embodiment of alimentation composition of the present invention, described alimentation composition comprises the component of following weight parts: albumen powder 28 parts, small peptide 5 parts, edible vegetable oil microcapsule powder 45 parts, dietary fiber 14 parts, maltodextrin 8 parts, B family vitamin 0.3 part.Research finds, under the composition of specified weight part, the effect that alimentation composition of the present invention improves the nutrition condition after Diabetic Nephropathy patients dialysis is better.
As the more preferably embodiment of alimentation composition of the present invention, described albumen powder is made up of PURE WHEY and skimmed milk power; Described small peptide is ovalbumin peptide; Described edible vegetable oil microcapsule powder with sunflower oil and linseed oil for raw material is prepared from; Described dietary fiber is made up of FOS and resistant dextrin; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.
As the preferred embodiment of alimentation composition of the present invention, described edible vegetable oil microcapsule powder with more than one materials in sunflower oil, safflower seed oil, linseed oil and Purple Perilla Seed Oil for raw material is prepared from.
As the preferred embodiment of alimentation composition of the present invention, containing linoleic acid and leukotrienes in described edible vegetable oil microcapsule powder, linoleic acid and linolenic mass ratio are 4 ~ 6:1.Wherein, linoleic acid and leukotrienes all have the effect protecting cardiovascular and cerebrovascular, and after the two carries out scientific matching, the effect of its protection cardiovascular and cerebrovascular is better.
As the preferred embodiment of alimentation composition of the present invention, described albumen powder is at least one in PURE WHEY, casein, skimmed milk power, Egg-white and soybean protein isolate.
As the preferred embodiment of alimentation composition of the present invention, described small peptide is at least one in ovalbumin peptide, marine collagen protein peptides, soybean oligopeptide and whey protein peptide.
As the preferred embodiment of alimentation composition of the present invention, described dietary fiber is at least one in oligoisomaltose, FOS, xylo-oligosaccharide, resistant dextrin and inulin.
As the preferred embodiment of alimentation composition of the present invention, described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.
Present invention also offers the preparation method of above-mentioned alimentation composition, said method comprising the steps of:
B family vitamin, small peptide and dietary fiber are mixed, obtains mixed powder A;
Albumen powder and maltodextrin are mixed, obtains mixed powder B;
By the mixer mixing 20 ~ 40 minutes of mixed powder A, mixed powder B and edible vegetable oil microcapsule powder, obtained alimentation composition.
As the preferred embodiment of the preparation method of alimentation composition of the present invention, described B family vitamin, small peptide and dietary fiber adopt equal increments method to mix, and obtain mixed powder A; Described albumen powder and maltodextrin adopt equal increments method to mix, and obtain mixed powder B.
The instructions of taking of alimentation composition of the present invention is: every day takes 50g, and 2 ~ 3 times of warm water or cold water reconstitute to be taken.
Beneficial effect of the present invention is:
1) provide enough energy, meet the ratio that dialysis crowd per kilogram of body weight every day recommends to take in heat (23kcal) and protein (1.0g);
2) contained nitrogenous source is from high-quality animal protein and food source property small peptide, is easy to absorb, does not increase kidney burden;
3) low GI, Diabetic Nephropathy patients can be made effectively to carry out Blood sugar management, and the professional Medical Degree for Diabetic Nephropathy patients has remarkable result;
4) containing multivitamin, the nutrition of Diabetic Nephropathy patients because of dialysis loss can be supplemented rapidly;
5) dietary fiber promotes the breeding of probio in intestines, suppresses growing of spoilage organisms simultaneously, intestinal mucosa is formed one protective barrier, reduces the absorption of harmful substance; In addition promote intestines peristalsis, keep Intestinal Mucosal Injury in Patients Undergoing smooth and easy;
6) vegetable fat Linoleic acid and leukotrienes ratio meet 4 ~ 6:1.After special process process, product 2 ~ 3 times of temperature (cool) water and rapidly dissolvable, do not increase the burden caused patient;
7) thing sodium of the present invention, potassium, phosphorus content are low, effectively can alleviate sodium, potassium, phosphorus to the burden of kidney;
8) product is fine and smooth fragrant sliding, and patient is easy to accept.
In addition, alimentation composition preparation method of the present invention is simple.
Accompanying drawing explanation
Fig. 1 is preparation technology's flow chart of alimentation composition of the present invention.
Detailed description of the invention
For better the object, technical solutions and advantages of the present invention being described, below in conjunction with the drawings and specific embodiments, the invention will be further described.
Embodiment 1
A kind of embodiment of alimentation composition of the present invention, alimentation composition described in the present embodiment comprises the component of following weight parts: albumen powder 28 parts, small peptide 5 parts, edible vegetable oil microcapsule powder 45 parts, dietary fiber 14 parts, maltodextrin 8 parts, B family vitamin 0.3 part; Wherein, described albumen powder is made up of PURE WHEY and skimmed milk power; Described small peptide is ovalbumin peptide; Described edible vegetable oil microcapsule powder with sunflower oil and linseed oil for raw material is prepared from; Described dietary fiber is made up of FOS and resistant dextrin; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.
The preparation method of alimentation composition described in the present embodiment is: adopt equal increments method to mix B family vitamin, small peptide and dietary fiber, obtain mixed powder A; Adopt equal increments method to mix albumen powder and maltodextrin, obtain mixed powder B; By the mixer mixing 20 ~ 40 minutes of mixed powder A, mixed powder B and edible vegetable oil microcapsule powder, obtained alimentation composition.
After testing, find in the above-mentioned alimentation composition of every 100g (pulvis) containing the nutritional labeling shown in table 1.
Table 1
From table 1, alimentation composition 1 of the present invention) enough energy is provided, meet the ratio that dialysis crowd per kilogram of body weight every day recommends to take in heat (23kcal) and protein (1.0g); 2) hypoglycemia patient (GI), Diabetic Nephropathy patients can be made effectively to carry out Blood sugar management, and the professional Medical Degree for Diabetic Nephropathy patients has remarkable result; 3) containing multivitamin, the nutrition of Diabetic Nephropathy patients because of dialysis loss can be supplemented rapidly; 4) vegetable fat Linoleic acid and leukotrienes ratio meet 4 ~ 6:1; 5) sodium, potassium, phosphorus content are low, effectively can alleviate sodium, potassium, phosphorus to the burden of kidney.
Embodiment 2
A kind of embodiment of alimentation composition of the present invention, alimentation composition described in the present embodiment comprises the component of following weight parts: albumen powder 1 part, small peptide 20 parts, edible vegetable oil microcapsule powder 34 parts, dietary fiber 30 parts, maltodextrin 15 parts, B family vitamin 0.1 part; Wherein, described albumen powder is PURE WHEY; Described small peptide is marine collagen protein peptides; Described edible vegetable oil microcapsule powder is that raw material is prepared from safflower seed oil; Described dietary fiber is oligoisomaltose; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.The preparation method of alimentation composition described in the present embodiment is with embodiment 1.
Embodiment 3
A kind of embodiment of alimentation composition of the present invention, alimentation composition described in the present embodiment comprises the component of following weight parts: albumen powder 50 parts, small peptide 15 parts, edible vegetable oil microcapsule powder 10 parts, dietary fiber 23 parts, maltodextrin 1 part, B family vitamin 1 part; Wherein, described albumen powder is casein; Described small peptide is soybean oligopeptide; Described edible vegetable oil microcapsule powder is with sunflower oil and Purple Perilla Seed Oil for raw material is prepared from, and edible vegetable oil microcapsule powder Linoleic acid and linolenic mass ratio are 4:1; Described dietary fiber is xylo-oligosaccharide; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.The preparation method of alimentation composition described in the present embodiment is with embodiment 1.
Embodiment 4
A kind of embodiment of alimentation composition of the present invention, alimentation composition described in the present embodiment comprises the component of following weight parts: albumen powder 20 parts, small peptide 1 part, edible vegetable oil microcapsule powder 70 parts, dietary fiber 1 part, maltodextrin 8 parts, B family vitamin 0.3 part; Wherein, described albumen powder is soybean protein isolate; Described small peptide is made up of ovalbumin peptide and marine collagen protein peptides; Described edible vegetable oil microcapsule powder is with sunflower oil and linseed oil for raw material is prepared from, and edible vegetable oil microcapsule powder Linoleic acid and linolenic mass ratio are 6:1; Described dietary fiber is inulin; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.The preparation method of alimentation composition described in the present embodiment is with embodiment 1.
Embodiment 5
A kind of embodiment of alimentation composition of the present invention, alimentation composition described in the present embodiment comprises the component of following weight parts: albumen powder 20 parts, small peptide 20 parts, edible vegetable oil microcapsule powder 20 parts, dietary fiber 10 parts, maltodextrin 30 parts, B family vitamin 0.1 part; Wherein, described albumen powder is Egg-white; Described small peptide is whey protein peptide; Described edible vegetable oil microcapsule powder is with linseed oil and safflower seed oil for raw material is prepared from, and edible vegetable oil microcapsule powder Linoleic acid and linolenic mass ratio are 5:1; Described dietary fiber is FOS; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.The preparation method of alimentation composition described in the present embodiment is with embodiment 1.
Embodiment 6
The present embodiment, for the alimentation composition of embodiment 1, has investigated the impact of nutritional support on Diabetic Nephropathy Patients sugar.
Standard: by under doctor's medication prerequisite, fasting blood-glucose 6.1 ~ 7.1mmol/L, after the meal two hours blood glucose 7.2 ~ 8.8mmol/L.
Select the routine patient of Diabetic Nephropathy patients 30 according to standard and enter group, be divided at random three groups (control group, normal group, test group), between group patient before the meal with postprandial blood sugar without significant difference.Control group 10 example, gives oral 75g DEXTROSE ANHYDROUS (be dissolved in 300ml water, take in 5 minutes); Normal group 10 example, gives normal diet; Test group 10 example, gives the alimentation composition 50g of embodiment 1, and normal diet.Respectively to the fasting blood-glucose of three groups of patients and after the meal 2 hours blood glucoses fluctuation situations be analyzed, comparative analysis result is as shown in table 2.
Table 2
Note: * represents there is significant difference (P < 0.05) compared with control group
Significant difference is had compared with the blood sugar that table 2 shows normal group and test group blood sugar and the control group 2h after the meal of 2h after the meal, and without significant difference between normal group and test group, no significant difference (P>0.05).Show that alimentation composition of the present invention can not cause patient blood glucose to fluctuate widely.
Embodiment 7
The present embodiment, for the alimentation composition of embodiment 1, investigates nutritional support to the impact after Diabetic Nephropathy patients dialysis.The selected routine patient of Maintenance Hemodialysis Patients (being diagnosed as diabetic nephropathy) 40 enters group.Be divided at random two groups (control group, test group), two groups of patients the age, sex, morbidity kind, albumin, prealbumin, c reactive protein, triglycerides, cholesterol, HDL, low-density lipoprotein, body weight, waistline, triceps muscle of arm skinfold, upper-arm circumference, arm muscle circumference, every day protein intake, in every day Energy intaking amount etc. all without significant difference.Control group patient is totally 20 examples, and patient carries out daily full diet; Test group patient is totally 20 examples, and patient, on full diet basis, gives the alimentation composition (every day 50g, 2 ~ 3 times of warm water or cold water reconstitute to be taken) of embodiment 1 in each blood dialysis.The nutritional intervention time is 6 months, carries out indices inspection after 6 months, with comparing before intervention.Before and after nutritional intervention, the result that patient's nutritive index compares is as shown in table 3, the result that patient's inflammation index and immunologic function compare is as shown in table 4, and the result that patients with lipid (mmol/L) compares is as shown in table 5, and between patient and group, the result of anthropometry Indexes Comparison is as shown in table 6.
Table 3
Note: * represents that corresponding group patients before and after intervention has significant difference (P < 0.05)
Table 3 shows test group patients before and after intervention seralbumin, serum prealbumin, transferrins obviously raise, and difference has statistical significance (P<0.05).Control group patients before and after intervention then changes not obvious.
Table 4
Table 4 shows leukocyte count between patient's patients before and after intervention and group, neutrophil leucocyte number, c reactive protein, lymphocyte number all do not have significant change, no significant difference (P>0.05).
Table 5
Table 5 shows triglycerides, T-CHOL, HDL, low-density lipoprotein, VLDL between patient's patients before and after intervention and group does not all have significant change, no significant difference (P>0.05).
Table 6
Table 6 shows body weight, upper-arm circumference, arm muscle circumference, grip before and after test group treatment and is significantly increased (P<0.05).
From table 3 ~ 6, alimentation composition of the present invention can improve the nutrition condition after Hemodialysis for Diabetic Nephropathy, especially the albumin, prealbumin, transferrins, body weight, upper-arm circumference, arm muscle circumference, grip etc. of patient are improved significantly, on the inflammation index of patient, immunologic function, lipid-metabolism all without impact.
Finally to should be noted that; above embodiment is only in order to illustrate technical scheme of the present invention but not limiting the scope of the invention; although be explained in detail the present invention with reference to preferred embodiment; those of ordinary skill in the art is to be understood that; can modify to technical scheme of the present invention or equivalent replacement, and not depart from essence and the scope of technical solution of the present invention.
Claims (10)
1. an alimentation composition, is characterized in that: described alimentation composition comprises the component of following weight parts: albumen powder 1-50 part, small peptide 1-20 part, edible vegetable oil microcapsule powder 10-70 part, dietary fiber 1-30 part, maltodextrin 1-30 part, B family vitamin 0.1-1 part.
2. alimentation composition as claimed in claim 1, is characterized in that: described alimentation composition comprises the component of following weight parts: albumen powder 28 parts, small peptide 5 parts, edible vegetable oil microcapsule powder 45 parts, dietary fiber 14 parts, maltodextrin 8 parts, B family vitamin 0.3 part.
3. alimentation composition as claimed in claim 2, is characterized in that: described albumen powder is made up of PURE WHEY and skimmed milk power; Described small peptide is ovalbumin peptide; Described edible vegetable oil microcapsule powder with sunflower oil and linseed oil for raw material is prepared from; Described dietary fiber is made up of FOS and resistant dextrin; Described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.
4. alimentation composition as claimed in claim 1, is characterized in that: described edible vegetable oil microcapsule powder with more than one materials in sunflower oil, safflower seed oil, linseed oil and Purple Perilla Seed Oil for raw material is prepared from.
5. the alimentation composition as described in claim 1 or 4, is characterized in that: containing linoleic acid and leukotrienes in described edible vegetable oil microcapsule powder, linoleic acid and linolenic mass ratio are 4 ~ 6:1.
6. alimentation composition as claimed in claim 1, is characterized in that: described albumen powder is at least one in PURE WHEY, casein, skimmed milk power, Egg-white and soybean protein isolate.
7. alimentation composition as claimed in claim 1, is characterized in that: described small peptide is at least one in ovalbumin peptide, marine collagen protein peptides, soybean oligopeptide and whey protein peptide.
8. alimentation composition as claimed in claim 1, is characterized in that: described dietary fiber is at least one in oligoisomaltose, FOS, xylo-oligosaccharide, resistant dextrin and inulin.
9. alimentation composition as claimed in claim 1, is characterized in that: described B family vitamin is made up of vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid and pantothenic acid.
10. a preparation method for alimentation composition as claimed in claim 1, is characterized in that: said method comprising the steps of:
B family vitamin, small peptide and dietary fiber are mixed, obtains mixed powder A;
Albumen powder and maltodextrin are mixed, obtains mixed powder B;
By the mixer mixing 20 ~ 40 minutes of mixed powder A, mixed powder B and edible vegetable oil microcapsule powder, obtained alimentation composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510528459.3A CN105211884A (en) | 2015-08-25 | 2015-08-25 | For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510528459.3A CN105211884A (en) | 2015-08-25 | 2015-08-25 | For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105211884A true CN105211884A (en) | 2016-01-06 |
Family
ID=54981497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510528459.3A Pending CN105211884A (en) | 2015-08-25 | 2015-08-25 | For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105211884A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343566A (en) * | 2016-08-30 | 2017-01-25 | 李洋 | Special medical food formulation and the production process thereof for patients with chronic nephropathy |
| CN106666716A (en) * | 2016-11-21 | 2017-05-17 | 北京康百世科技发展有限公司 | Total-nutrient formula food for diabetic patients and preparation method thereof |
| CN107080235A (en) * | 2016-06-30 | 2017-08-22 | 健糖（北京）健康管理有限公司 | Formula food and its preparation technology that a kind of confession diabetic nephropathy crowd eats |
| CN107432481A (en) * | 2017-08-07 | 2017-12-05 | 中国大冢制药有限公司 | A kind of diet fiber composition and preparation method thereof |
| CN107751992A (en) * | 2016-08-23 | 2018-03-06 | 华仁药业股份有限公司 | Merge enteral nutritional composition of nephrotic and preparation method thereof for diabetes |
| CN107822116A (en) * | 2017-11-13 | 2018-03-23 | 福建省水产研究所（福建水产病害防治中心） | Suitable for the ocean short peptide type special medicine purposes formula food of diabetic |
| CN108142951A (en) * | 2018-01-31 | 2018-06-12 | 广州纽健生物科技有限公司 | Improve nutraceutical of postoperative insulin resistance and its preparation method and application |
| CN109007840A (en) * | 2018-09-18 | 2018-12-18 | 广东雪芝康生物科技有限公司 | A kind of nutritive plant powder and preparation method thereof by adjusting gene reducing weight and blood fat |
| CN109247483A (en) * | 2017-07-13 | 2019-01-22 | 上海冬泽特医食品有限公司 | A kind of solid beverage and preparation method thereof for Rend dialysis patients |
| CN109247482A (en) * | 2017-07-13 | 2019-01-22 | 上海冬泽特医食品有限公司 | Diabetic's solid beverage and preparation method thereof |
| WO2019017800A1 (en) * | 2017-07-18 | 2019-01-24 | Punzalan A Emma | Palatable low-glycemic nutritional drink |
| CN111227224A (en) * | 2018-11-10 | 2020-06-05 | 江西乐迪医疗科技有限公司 | Medical formula food helpful for protecting kidney function of diabetic nephropathy patient |
| CN112715930A (en) * | 2021-01-04 | 2021-04-30 | 湖南慧泽生物医药科技有限公司 | Formula food for diabetic patients |
| CN112970806A (en) * | 2021-04-19 | 2021-06-18 | 刘岩 | Nutritional food formula for patients with nephropathy |
| CN113349374A (en) * | 2020-03-06 | 2021-09-07 | 柴凤臣 | Peony seed oil peptide microcapsule powder |
| CN114869995A (en) * | 2022-03-24 | 2022-08-09 | 大医声科技(北京)有限公司 | Multivitamin nutrient formula suitable for diabetic patients |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496577A (en) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | Special diet and foodstuffs formula containing small peptide for patient with kidney disease |
| CN103284042A (en) * | 2013-06-03 | 2013-09-11 | 吉林大学 | Egg-white protein peptide containing enteral nutrition preparation and preparation method thereof |
| CN103478545A (en) * | 2013-08-28 | 2014-01-01 | 山东卫康生物医药科技有限公司 | Coarse grain total-nutrient formula food for nephritic patients |
| CN104187711A (en) * | 2014-07-30 | 2014-12-10 | 广东省农业科学院蚕业与农产品加工研究所 | Intacted protein and short peptide compound type special-dietary nutritional emulsion of clinic patients and preparation method of intacted protein and short peptide compound type special-dietary nutritional emulsion |
| CN104379172A (en) * | 2012-06-28 | 2015-02-25 | 株式会社明治 | Nutritional composition |
-
2015
- 2015-08-25 CN CN201510528459.3A patent/CN105211884A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496577A (en) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | Special diet and foodstuffs formula containing small peptide for patient with kidney disease |
| CN104379172A (en) * | 2012-06-28 | 2015-02-25 | 株式会社明治 | Nutritional composition |
| CN103284042A (en) * | 2013-06-03 | 2013-09-11 | 吉林大学 | Egg-white protein peptide containing enteral nutrition preparation and preparation method thereof |
| CN103478545A (en) * | 2013-08-28 | 2014-01-01 | 山东卫康生物医药科技有限公司 | Coarse grain total-nutrient formula food for nephritic patients |
| CN104187711A (en) * | 2014-07-30 | 2014-12-10 | 广东省农业科学院蚕业与农产品加工研究所 | Intacted protein and short peptide compound type special-dietary nutritional emulsion of clinic patients and preparation method of intacted protein and short peptide compound type special-dietary nutritional emulsion |
Non-Patent Citations (1)
| Title |
|---|
| 郑芳: "饮食及营养指导在糖尿病肾病行血液透析患者中的应用效果", 《当代护士》 * |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107080235A (en) * | 2016-06-30 | 2017-08-22 | 健糖（北京）健康管理有限公司 | Formula food and its preparation technology that a kind of confession diabetic nephropathy crowd eats |
| CN107751992A (en) * | 2016-08-23 | 2018-03-06 | 华仁药业股份有限公司 | Merge enteral nutritional composition of nephrotic and preparation method thereof for diabetes |
| CN106343566A (en) * | 2016-08-30 | 2017-01-25 | 李洋 | Special medical food formulation and the production process thereof for patients with chronic nephropathy |
| CN106666716A (en) * | 2016-11-21 | 2017-05-17 | 北京康百世科技发展有限公司 | Total-nutrient formula food for diabetic patients and preparation method thereof |
| CN109247483A (en) * | 2017-07-13 | 2019-01-22 | 上海冬泽特医食品有限公司 | A kind of solid beverage and preparation method thereof for Rend dialysis patients |
| CN109247482A (en) * | 2017-07-13 | 2019-01-22 | 上海冬泽特医食品有限公司 | Diabetic's solid beverage and preparation method thereof |
| WO2019017800A1 (en) * | 2017-07-18 | 2019-01-24 | Punzalan A Emma | Palatable low-glycemic nutritional drink |
| CN107432481A (en) * | 2017-08-07 | 2017-12-05 | 中国大冢制药有限公司 | A kind of diet fiber composition and preparation method thereof |
| CN107822116A (en) * | 2017-11-13 | 2018-03-23 | 福建省水产研究所（福建水产病害防治中心） | Suitable for the ocean short peptide type special medicine purposes formula food of diabetic |
| CN108142951A (en) * | 2018-01-31 | 2018-06-12 | 广州纽健生物科技有限公司 | Improve nutraceutical of postoperative insulin resistance and its preparation method and application |
| CN109007840A (en) * | 2018-09-18 | 2018-12-18 | 广东雪芝康生物科技有限公司 | A kind of nutritive plant powder and preparation method thereof by adjusting gene reducing weight and blood fat |
| CN111227224A (en) * | 2018-11-10 | 2020-06-05 | 江西乐迪医疗科技有限公司 | Medical formula food helpful for protecting kidney function of diabetic nephropathy patient |
| CN113349374A (en) * | 2020-03-06 | 2021-09-07 | 柴凤臣 | Peony seed oil peptide microcapsule powder |
| CN112715930A (en) * | 2021-01-04 | 2021-04-30 | 湖南慧泽生物医药科技有限公司 | Formula food for diabetic patients |
| CN112970806A (en) * | 2021-04-19 | 2021-06-18 | 刘岩 | Nutritional food formula for patients with nephropathy |
| CN114869995A (en) * | 2022-03-24 | 2022-08-09 | 大医声科技(北京)有限公司 | Multivitamin nutrient formula suitable for diabetic patients |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105211884A (en) | For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof | |
| US20210352948A1 (en) | Composition for treating diabetes based on traditional Chinese medicine nutritional therapy and application thereof | |
| CN101496580B (en) | Special diet and foodstuffs formula containing small peptide for diabetic | |
| CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
| CN104286849A (en) | Diabetes-specific enteral nutrition multi-polymerization agent | |
| CN102648752B (en) | Engineering rice suitable for people having unbalanced diet and with function of reducing blood glucose and preparation method of engineering rice | |
| CN102599216B (en) | Preparation method of vegetable health biscuit | |
| CN103238897A (en) | Composite plant solid drink suitable for diabetic patients | |
| CN102113648A (en) | Special dietary noodle applicable to people suffering from 'five-high' metabolic syndrome and preparation method thereof | |
| CN101473953A (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
| CN101991019A (en) | Traditional Chinese medicine chicken feed and production method of silky fowl egg capable of tonifying kidney, strengthening yang and resisting fatigue | |
| CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
| CN108142938A (en) | Control special medicine purposes formula food meal replacement powder of blood glucose and preparation method thereof | |
| CN106805221A (en) | Fat-reducing nutritional intervention generation meal nutrition bar | |
| CN102048225B (en) | Red-date health protection beverage capable of improving growing development | |
| CN102599217A (en) | Health biscuits for lowering blood glucose and lipid | |
| CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
| CN102640900A (en) | Fast nutritional staple food for diabetes and preparation method thereof | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| CN108208802A (en) | A kind of special diet of suitable patients with diabetes mellitus and preparation method thereof | |
| CN107212416A (en) | A kind of preparation method and application of diabetes full nutrition formula food | |
| CN102461587A (en) | Selenium-rich folium mori black grain flour food for preventing and treating diabetes | |
| CN102113652A (en) | Special dietary extruded rice applicable to patients suffering from 'five-high' metabolic syndrome and preparation method thereof | |
| CN104286841A (en) | Total nutrient preparation for stroke patients | |
| JP2008247748A (en) | Nutritive composition for dialysis patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160106 |